Cargando…
Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis
Background: People with chronic pain (CP) sometimes report impaired cognitive function, including a deficit of attention, memory, executive planning, and information processing. However, the association between CP and cognitive decline was still not clear. Our study aimed to assess the association o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492915/ https://www.ncbi.nlm.nih.gov/pubmed/34630023 http://dx.doi.org/10.3389/fnins.2021.737874 |
_version_ | 1784579014729400320 |
---|---|
author | Zhang, Xueying Gao, Rui Zhang, Changteng Chen, Hai Wang, Ruiqun Zhao, Qi Zhu, Tao Chen, Chan |
author_facet | Zhang, Xueying Gao, Rui Zhang, Changteng Chen, Hai Wang, Ruiqun Zhao, Qi Zhu, Tao Chen, Chan |
author_sort | Zhang, Xueying |
collection | PubMed |
description | Background: People with chronic pain (CP) sometimes report impaired cognitive function, including a deficit of attention, memory, executive planning, and information processing. However, the association between CP and cognitive decline was still not clear. Our study aimed to assess the association of CP as a risk factor with cognitive decline among adults. Methods: We included data from clinical studies. Publications were identified using a systematic search strategy from PubMed, Embase, and Cochrane Library databases from inception to October 10, 2020. We used the mean cognitive outcome data and the standard deviations from each group. The standardized mean difference (SMD) or odds ratio (OR), and 95% confidence intervals (CI) were performed for each cognitive decline outcome. I(2)-values were assessed to quantify the heterogeneities. Results: We included 37 studies with a total of 52,373 patients with CP and 80,434 healthy control participants. Because these studies used different evaluative methods, we analyzed these studies. The results showed CP was associated with cognitive decline when the short-form 36 health survey questionnaire (SF-36) mental component summary (SMD = −1.50, 95% CI = −2.19 to −0.81), the Montreal cognitive assessment (SMD = −1.11, 95% CI = −1.60 to −0.61), performance validity testing (SMD = 3.05, 95% CI = 1.74 to 4.37), or operation span (SMD = −1.83, 95% CI = −2.98 to −0.68) were used. However, we got opposite results when the studies using International Classification of Diseases and Related Health Problems classification (OR = 1.58, 95% CI = 0.97 to 2.56), the Mini-Mental State Examination (SMD = −0.42, 95% CI = −0.94 to 0.10; OR = 1.14, 95% CI = 0.91 to 1.42), and Repeatable Battery for the Assessment of Neuropsychological Status memory component (SMD = −0.06, 95% CI = −0.37 to 0.25). Conclusion: There may be an association between CP and the incidence of cognitive decline when some cognitive, evaluative methods were used, such as short-form 36 health survey questionnaire, Montreal cognitive assessment, performance validity testing, and operation span. |
format | Online Article Text |
id | pubmed-8492915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84929152021-10-07 Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis Zhang, Xueying Gao, Rui Zhang, Changteng Chen, Hai Wang, Ruiqun Zhao, Qi Zhu, Tao Chen, Chan Front Neurosci Neuroscience Background: People with chronic pain (CP) sometimes report impaired cognitive function, including a deficit of attention, memory, executive planning, and information processing. However, the association between CP and cognitive decline was still not clear. Our study aimed to assess the association of CP as a risk factor with cognitive decline among adults. Methods: We included data from clinical studies. Publications were identified using a systematic search strategy from PubMed, Embase, and Cochrane Library databases from inception to October 10, 2020. We used the mean cognitive outcome data and the standard deviations from each group. The standardized mean difference (SMD) or odds ratio (OR), and 95% confidence intervals (CI) were performed for each cognitive decline outcome. I(2)-values were assessed to quantify the heterogeneities. Results: We included 37 studies with a total of 52,373 patients with CP and 80,434 healthy control participants. Because these studies used different evaluative methods, we analyzed these studies. The results showed CP was associated with cognitive decline when the short-form 36 health survey questionnaire (SF-36) mental component summary (SMD = −1.50, 95% CI = −2.19 to −0.81), the Montreal cognitive assessment (SMD = −1.11, 95% CI = −1.60 to −0.61), performance validity testing (SMD = 3.05, 95% CI = 1.74 to 4.37), or operation span (SMD = −1.83, 95% CI = −2.98 to −0.68) were used. However, we got opposite results when the studies using International Classification of Diseases and Related Health Problems classification (OR = 1.58, 95% CI = 0.97 to 2.56), the Mini-Mental State Examination (SMD = −0.42, 95% CI = −0.94 to 0.10; OR = 1.14, 95% CI = 0.91 to 1.42), and Repeatable Battery for the Assessment of Neuropsychological Status memory component (SMD = −0.06, 95% CI = −0.37 to 0.25). Conclusion: There may be an association between CP and the incidence of cognitive decline when some cognitive, evaluative methods were used, such as short-form 36 health survey questionnaire, Montreal cognitive assessment, performance validity testing, and operation span. Frontiers Media S.A. 2021-09-22 /pmc/articles/PMC8492915/ /pubmed/34630023 http://dx.doi.org/10.3389/fnins.2021.737874 Text en Copyright © 2021 Zhang, Gao, Zhang, Chen, Wang, Zhao, Zhu and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Zhang, Xueying Gao, Rui Zhang, Changteng Chen, Hai Wang, Ruiqun Zhao, Qi Zhu, Tao Chen, Chan Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis |
title | Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis |
title_full | Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis |
title_fullStr | Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis |
title_short | Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis |
title_sort | evidence for cognitive decline in chronic pain: a systematic review and meta-analysis |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492915/ https://www.ncbi.nlm.nih.gov/pubmed/34630023 http://dx.doi.org/10.3389/fnins.2021.737874 |
work_keys_str_mv | AT zhangxueying evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis AT gaorui evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis AT zhangchangteng evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis AT chenhai evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis AT wangruiqun evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis AT zhaoqi evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis AT zhutao evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis AT chenchan evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis |